Valbiotis R&D Riom Center, 63200 Riom, France.
Valbiotis R&D Riom Center, 63200 Riom, France.
Nutr Res. 2023 Oct;118:70-84. doi: 10.1016/j.nutres.2023.07.010. Epub 2023 Aug 3.
Global prevalence of obesity and type 2 diabetes are rapidly increasing to pandemic proportions. A novel supplement composed of 5 plant extracts from olive leaf, bilberry, artichoke, chrysanthellum, and black pepper was designed to prevent type 2 diabetes development in people at risk. It was previously shown to improve body weight and glucose control in preclinical rodent models, with these effects being accompanied by increased fecal energy excretion and in vitro inhibition of several digestive enzymes. Thus, we hypothesized that, in mice fed a high-fat diet (HFD), a single dose of this botanical supplementation would decrease the responses to oral fat and carbohydrate tolerance tests, and that chronic supplementation would result in increased fecal triglyceride content. We showed that acute administration in HFD-fed mice (1.452 g/kg body weight) markedly reduced circulating triglycerides following an oral lipid gavage, whereas glycemic responses to various carbohydrate tests were only mildly affected. When incorporated into the food (2.5%) of HFD-fed mice, chronic supplementation prevented body weight gain and improved glucose homeostasis and lipid tolerance. Fecal free fatty acid content, but not triglyceride, was significantly increased in supplemented animals, suggesting reduced lipid absorption in the digestive tract. Congruently, this botanical supplementation downregulated several genes associated with fatty acid transport whose expression was increased by HFD, principally in the jejunum. This study provides novel insights as for the mode of action behind the antiobesity effect of this plant-based supplementation, in HFD-fed mice.
全球肥胖症和 2 型糖尿病的患病率迅速上升至流行程度。一种新型的补充剂由橄榄叶、越橘、朝鲜蓟、 Chrysanthellum 和黑胡椒的 5 种植物提取物组成,旨在预防有患病风险的人群患上 2 型糖尿病。先前的研究表明,它可以改善临床前啮齿动物模型的体重和葡萄糖控制,这些效果伴随着粪便能量排泄增加和体外抑制几种消化酶。因此,我们假设,在高脂肪饮食(HFD)喂养的小鼠中,单次给予这种植物补充剂会降低口服脂肪和碳水化合物耐量试验的反应,而慢性补充会导致粪便甘油三酯含量增加。我们表明,在 HFD 喂养的小鼠中(1.452 g/kg 体重)急性给药可显著降低口服脂质灌胃后的循环甘油三酯,而各种碳水化合物试验的血糖反应仅受到轻度影响。当将其纳入 HFD 喂养的小鼠的食物(2.5%)中时,慢性补充可预防体重增加,改善葡萄糖稳态和脂质耐受性。补充剂动物的粪便游离脂肪酸含量(但不是甘油三酯)显著增加,表明消化道的脂质吸收减少。与此一致,这种植物补充剂下调了几种与脂肪酸转运相关的基因的表达,这些基因的表达在 HFD 喂养时增加,主要在空肠中。这项研究为 HFD 喂养小鼠中这种基于植物的补充剂的减肥作用的作用机制提供了新的见解。